Different approaches for obtaining antibodies from human B cells

Area of Science:

• Immunology
• Biotechnology
• Therapeutic antibody development

Background:

• Antibodies are vital therapeutics for various human diseases.
• Early antibody therapies relied on animal models, often eliciting immune responses.
• Human antibodies are now preferred to reduce immunogenicity.

Purpose of the Study:

• To review methods for obtaining therapeutic antibodies directly from human B cells.
• To highlight techniques for isolating human antibodies from both antigen-exposed and naive B cell sources.

Main Methods:

• Review of techniques including cell line generation, single-cell isolation, display technologies, and B cell library construction.
• Utilizing B cells from both antigen-exposed and naive human donors.
• Focus on direct isolation of human antibodies.

Main Results:

• Multiple methods exist for generating human antibodies directly from human B cells.
• These methods enable the isolation of specific antibodies for therapeutic applications.
• The choice of method depends on the B cell source and desired antibody characteristics.

Conclusions:

• Direct isolation of human antibodies from B cells is a key strategy in modern antibody therapeutics.
• These approaches circumvent issues associated with non-human antibodies, improving safety and efficacy.
• Continued development of these techniques will advance the field of antibody-based medicine.